According to Yang et al., 2020 [30], the disparity observed in the results among different studies on schizophrenia (SZ) could be related to several aspects, such as long-term treatment conditioning, ethnicity, intrinsic SZ heterogeneity, and some other potential confounding factors that could be altering IGF levels, such as albumin. This evidence concerns the gene IGF1 and schizophrenia.